FindTrial
Sign In

Safety and Efficacy of Ventricular Septal Defects Closure via Transradial Versus Transfemoral Approach: a multicenter, randomized, and controlled study

Safety and Efficacy of Ventricular Septal Defects Closure via Transradial Versus Transfemoral Approach: a multicenter, randomized, and controlled study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800015235
Enrollment
Unknown
Registered
2018-03-16
Start date
2018-04-01
Completion date
Unknown
Last updated
2018-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ventricular Septal Defect

Interventions

Transradial group:Transradial Approach
Transfemoral group:Transfemoral Approach

Sponsors

Department of Cardiology, Changhai Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age >18 years old; 2. the maximum diameter16 mm by transthoracic echocardiography (TTE); 3. the defect located at 9 to 12 oclock positions of an analog clock in the short axis parasternal view; 4. left to right shunt; and 5. pulmonary pressure<70 mm Hg by TTE.

Exclusion criteria

Exclusion criteria: Patients with aortic valve prolapse, severe aortic regurgitation, right to left shunt, severe cyanosis, pulmonary pressure >70 mmHg, and cardiac function class IV were excluded.

Design outcomes

Primary

MeasureTime frame
effectiveness;—

Countries

China

Contacts

Public ContactXianxian Zhao

Department of Cardiology, Changhai Hospital

13764924032@163.com+86 13601713431

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026